IPCA Laboratories soars on receiving USFDA nod for formulations' manufacturing unit in MP

04 Sep 2013 Evaluate

Ipca Laboratories is currently trading at Rs. 671.85, up by 25.25 points or 3.91% from its previous closing of Rs. 646.60 on the BSE.

The scrip opened at Rs. 651.25 and has touched a high and low of Rs. 681.45 and Rs. 644.00 respectively. So far 32722 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 708.00 on 11-Jul-2013 and a 52 week low of Rs. 401.10 on 08-Nov-2012.

Last one week high and low of the scrip stood at Rs. 681.45 and Rs. 610.00 respectively. The current market cap of the company is Rs. 8184.64 crore.

The promoters holding in the company stood at 45.89% while Institutions and Non-Institutions held 36.46% and 17.65% respectively.

IPCA Laboratories has received the US Food and Drug Administration (USFDA) acceptance for its oral solid dosage formulations' manufacturing facility situated at Pharmazone, SEZ Indore, Pithampur in state of Madhya Pradesh. This will enable the company to commercialize oral solid dosage formulations in the US market from this formulations manufacturing facility.

Last year in November, the company had decided that it will not manufacture any dosage formulations at its oral solid dosage formulations manufacturing facility and the dosage will not be commercialized for the US market. The company had taken this step as during the course of the internal quality assurance review it had noticed a few non-conformances at the said manufacturing unit. The company had voluntarily referred these to the USFDA and the same was under discussion with them for an appropriate resolution.

IPCA Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.

 

Ipca Laboratories Share Price

1459.30 2.15 (0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×